无抗胸腺细胞球蛋白的成人脐血移植后CD4+ T细胞稳健恢复
该研究分析106例未用抗胸腺细胞球蛋白(ATG)的成人脐血移植受者,中位年龄50岁,66%为急性白血病,96%接受清髓处理。CD4+ T细胞恢复快于CD8+,4个月时中位CD4+计数超过200/mm3,且较高CD4+计数与植物血凝素反应同总死亡率降低相关。
要点
- 无ATG成人脐血移植后CD4+ T细胞恢复迅速且稳健。
- 较高CD4+计数和植物血凝素反应与总死亡率降低相关。
- 巨细胞病毒再激活与CD8+ T细胞扩增及CD4+计数降低相关。
核心结论
- 无ATG的成人脐血移植与稳健的胸腺非依赖CD4+ T细胞恢复相关,且CD4+恢复降低死亡风险。
研究设计与样本
- 分析106例植入成功的成人脐血移植受者,中位年龄50岁(范围22-70),均接受环孢素/霉酚酸酯免疫预防且未用ATG。
主要发现
- CD4+ T细胞恢复快于CD8+ T细胞,中位CD4+计数在4个月时超过200/mm3。
- 移植后早期CD4+亚群以效应记忆和中央记忆细胞最常见,CD8+亚群以效应和效应记忆细胞最常见。
- 移植后6至9个月后初始T细胞亚群逐渐增加。
- 输注的脐血单位活CD3+细胞剂量较高与CD4+及CD4+CD45RA+ T细胞恢复改善相关。
- 第60天前巨细胞病毒再激活与总、效应记忆和效应CD8+ T细胞扩增相关,但CD4+计数较低;急性移植物抗宿主病未显著影响T细胞重建。
关键数值与推荐
- 中位CD4+ T细胞计数在4个月时超过200/mm3。
- 自然杀伤细胞和B细胞中位计数在4个月时分别达到252/mm3和150/mm3。
临床怎么用
- 成人脐血移植可不使用ATG,以促进CD4+ T细胞恢复。
- 监测CD4+ T细胞计数和植物血凝素反应可能有助于评估死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Quality of immune reconstitution after cord blood transplantation (CBT) without antithymocyte globulin (ATG) in adults is not established. We analyzed immune recovery in 106 engrafted adult CBT recipients (median age 50 years [range 22-70]) transplanted for hematologic malignancies with cyclosporine/mycophenolate mofetil immunoprophylaxis and no ATG. Patients were treated predominantly for acute leukemia (66%), and almost all (96%) underwent myeloablation. Recovery of CD4+ T cells was faster than CD8+ T cells with median CD4+ T-cell counts exceeding 200/mm3 at 4 months. Early post-CBT, effector memory (EM), and central memory cells were the most common CD4+ subsets, whereas effector and EM were the most common CD8+ T-cell subsets. Naive T-cell subsets increased gradually after 6 to 9 months post-CBT. A higher engrafting CB unit infused viable CD3+ cell dose was associated with improved CD4+ and CD4+CD45RA+ T-cell recovery. Cytomegalovirus reactivation by day 60 was associated with an expansion of total, EM, and effector CD8+ T cells, but lower CD4+ T-cell counts. Acute graft-versus-host disease (aGVHD) did not significantly compromise T-cell reconstitution. In serial landmark analyses, higher CD4+ T-cell counts and phytohemagglutinin responses were associated with reduced overall mortality. In contrast, CD8+ T-cell counts were not significant. Recovery of natural killer and B cells was prompt, reaching medians of 252/mm3 and 150/mm3 by 4 months, respectively, although B-cell recovery was delayed by aGVHD. Neither subset was significantly associated with mortality. ATG-free adult CBT is associated with robust thymus-independent CD4+ T-cell recovery, and CD4+ recovery reduced mortality risk.
引用
- Politikos I, Lavery JA, Hilden P, et al. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood Adv. 2020. PMID: 31935291. doi:10.1182/bloodadvances.2019000836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。